Why Palo Alto Networks Shares Are Trading Lower By Around 5%; Here Are 20 Stocks Moving Premarket

Shares of Palo Alto Networks, Inc. PANW fell in pre-market trading after reporting first-quarter results.

Palo Alto Networks reported quarterly earnings of $1.38 per share, above the analyst consensus estimate of $1.16. Revenue of $1.88 billion beat the analyst consensus estimate of $1.84 billion.

Billings clocked in at $2.024 billion, a 13.6% increase compared to $1.749 billion in the same period of 2022. Full-year 2024 total billings are expected to be in a range $10.7 billion to $10.8 billion, down from prior forecast of $10.9 billion to $11 billion.

Palo Alto Networks fell 5.2% to $242.82 in pre-market trading

Here are some other stocks moving in pre-market trading.

Gainers

Bone Biologics Corporation BBLG shares rose 62.1% to $0.8427 in pre-market trading after gaining around 9% on Wednesday.
Esports Entertainment Group, Inc. GMBL shares surged 37.4% to $0.0513 in pre-market trading after falling around 12% on Wednesday.
Chanson International Holding CHSN shares rose 20.7% to $1.75 in pre-market trading after dipping 35% on Wednesday.
Acutus Medical, Inc. AFIB shares rose 20.2% to $0.25 in pre-market trading after jumping around 24% on Wednesday. Acutus Medical recently reported third-quarter financial results and announced strategic realignment of resources and corporate restructuring by approximately 65%.
Yoshitsu Co., Ltd TKLF rose 18.5% to $0.8181 in pre-market trading after gaining over 10% on Wednesday.
BioVie Inc. BIVI shares climbed 14.3% to $3.60 in pre-market trading.
Heart Test Laboratories, Inc. HSCS shares rose 14.1% to $0.1712 in pre-market trading after falling around 17% on Wednesday.
SenesTech, Inc. SNES rose 11.2% to $0.2013 in pre-market trading. SenesTech announced a 1-for-12 reverse stock split.
CISO Global Inc. CISO gained 10.6% to $0.1769 in pre-market trading. CISO Global shares jumped 67% on Wednesday after the company announced its participation in the Microsoft Security Copilot Partner Private Preview.
CRISPR Therapeutics AG CRSP shares rose 5.8% to $59.50 in pre-market trading. -Vertex Pharmaceuticals and CRISPR Therapeutics said that the U.K. Medicines and Healthcare products Regulatory Agency has granted conditional marketing authorization for CASGEVY, a CRISPR/Cas9 gene-edited therapy, for the treatment of sickle cell disease and transfusion-dependent beta thalassemia.

Losers

Volcon, Inc. VLCN dipped 23.1% to $0.50 in pre-market trading after dipping 15% on Wednesday.
Augmedix, Inc. AUGX shares fell 22.8% to $4.19 in pre-market trading after the company reported pricing of upsized public offering of 6,250,000 shares of common stock.
Velo3D, Inc. VLD shares fell 16.3% to $1.18 in pre-market trading.
Alpine 4 Holdings, Inc. ALPP shares fell 14.4% to $0.82 in pre-market trading.
Chemomab Therapeutics Ltd. CMMB fell 14.1% to $0.7020 in pre-market. Chemomab Therapeutics shares jumped 34% on Wednesday after the company announced it received FDA fast track designation for CM-101 for the treatment of primary sclerosing cholangitis.
Sadot Group Inc. SDOT shares fell 12.3% to $0.5035 in pre-market trading. Sadot Group shares fell around 20% on Wednesday after the company reported a wider third-quarter loss.
Streamline Health Solutions, Inc. STRM fell 11.2% to $0.3045 in pre-market trading after declining 4% on Wednesday.
Cisco Systems, Inc. CSCO shares fell 11% to $47.43 in pre-market trading. Cisco reported upbeat earnings for its first quarter but lowered its earnings and sales projections for FY24.
Moxian (BVI) Inc MOXC shares fell 10.8% to $0.91 in pre-market trading.